PortfoliosLab logoPortfoliosLab logo
AT.L vs. CURE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

AT.L vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Ashtead Technology Holdings plc (AT.L) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

AT.L is traded in GBp, while CURE is traded in USD. To make them comparable, the CURE values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, AT.L achieves a 41.36% return, which is significantly higher than CURE's -8.39% return.


AT.L

1D
2.34%
1M
-9.15%
YTD
41.36%
6M
24.84%
1Y
3.96%
3Y*
5.46%
5Y*
10Y*

CURE

1D
2.45%
1M
16.59%
YTD
-8.39%
6M
-6.28%
1Y
36.82%
3Y*
1.46%
5Y*
3.58%
10Y*
13.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AT.L vs. CURE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AT.L
Ashtead Technology Holdings plc
41.36%-44.41%-8.83%95.43%75.24%10.96%
CURE
Direxion Daily Healthcare Bull 3x Shares
-8.39%13.82%-6.87%-13.93%-11.06%19.42%

Correlation

The correlation between AT.L and CURE is 0.10, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Nov 24, 2021

0.05

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AT.L vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AT.L
AT.L Risk / Return Rank: 4040
Overall Rank
AT.L Sharpe Ratio Rank: 4040
Sharpe Ratio Rank
AT.L Sortino Ratio Rank: 3838
Sortino Ratio Rank
AT.L Omega Ratio Rank: 3939
Omega Ratio Rank
AT.L Calmar Ratio Rank: 4040
Calmar Ratio Rank
AT.L Martin Ratio Rank: 4040
Martin Ratio Rank

CURE
CURE Risk / Return Rank: 2424
Overall Rank
CURE Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2727
Sortino Ratio Rank
CURE Omega Ratio Rank: 2424
Omega Ratio Rank
CURE Calmar Ratio Rank: 2424
Calmar Ratio Rank
CURE Martin Ratio Rank: 2222
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AT.L vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ashtead Technology Holdings plc (AT.L) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AT.LCUREDifference
Sharpe ratioReturn per unit of total volatility

-0.87

Sortino ratioReturn per unit of downside risk

-1.16

Omega ratioGain probability vs. loss probability

1.04

1.17

-0.12

Calmar ratioReturn relative to maximum drawdown

-0.01

1.13

-1.15

Martin ratioReturn relative to average drawdown

-0.03

2.64

-2.67

AT.L vs. CURE - Sharpe Ratio Comparison

The current AT.L Sharpe Ratio is -0.01, which is lower than the CURE Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of AT.L and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


AT.LCUREDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.01

0.86

-0.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.09

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.57

0.52

+0.05

Drawdowns

AT.L vs. CURE - Drawdown Comparison

The maximum AT.L drawdown since its inception was -65.60%, roughly equal to the maximum CURE drawdown of -65.03%. Use the drawdown chart below to compare losses from any high point for AT.L and CURE.


Loading charts...

Drawdown Indicators


AT.LCUREDifference

Max Drawdown

Largest peak-to-trough decline

-65.60%

-65.03%

-0.57%

Max Drawdown (1Y)

Largest decline over 1 year

-35.05%

-32.64%

-2.41%

Max Drawdown (3Y)

Largest decline over 3 years

-65.60%

-53.05%

-12.55%

Max Drawdown (5Y)

Largest decline over 5 years

-53.68%

Max Drawdown (10Y)

Largest decline over 10 years

-65.03%

Current Drawdown

Current decline from peak

-50.08%

-29.65%

-20.43%

Average Drawdown

Average peak-to-trough decline

-23.01%

-16.19%

-6.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.67%

13.96%

+6.71%

Volatility

AT.L vs. CURE - Volatility Comparison

The current volatility for Ashtead Technology Holdings plc (AT.L) is 13.79%, while Direxion Daily Healthcare Bull 3x Shares (CURE) has a volatility of 15.04%. This indicates that AT.L experiences smaller price fluctuations and is considered to be less risky than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AT.LCUREDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.79%

15.04%

-1.25%

Volatility (6M)

Calculated over the trailing 6-month period

31.29%

30.73%

+0.56%

Volatility (1Y)

Calculated over the trailing 1-year period

49.07%

43.11%

+5.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.95%

42.16%

+1.79%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

43.95%

48.60%

-4.65%

Dividends

AT.L vs. CURE - Dividend Comparison

AT.L's dividend yield for the trailing twelve months is around 0.30%, less than CURE's 1.18% yield.


PositionTTM202520242023202220212020201920182017
AT.L
Ashtead Technology Holdings plc
0.30%0.39%0.20%0.16%0.00%0.00%0.00%0.00%0.00%0.00%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.18%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%

Frequently Asked Questions


AT.L and CURE have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for AT.L and CURE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer